Kim Smith-Whitley

Chief Tech/Sci/R&D Officer at GLOBAL BLOOD THERAPEUTICS, INC.

63 year

Consumer Services

Health Technology

Profile

Kim Smith-Whitley is currently the Director at the Sickle Cell Disease Association of America, Inc. and the Executive VP, Head-Research & Development at Global Blood Therapeutics, Inc. Dr. Smith-Whitley holds a doctorate degree from George Washington University.

Kim Smith-Whitley active positions

Companies	Position	Start
GLOBAL BLOOD THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2021-04-30
Sickle Cell Disease Association of America, Inc.	Director/Board Member	-

All active positions of Kim Smith-Whitley

Training of Kim Smith-Whitley

George Washington University

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kim Smith-Whitley's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Sickle Cell Disease Association of America, Inc.
Global Blood Therapeutics, Inc. Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.	Health Technology